WO2007090247A1 - Nebuliser - Google Patents

Nebuliser Download PDF

Info

Publication number
WO2007090247A1
WO2007090247A1 PCT/AU2007/000147 AU2007000147W WO2007090247A1 WO 2007090247 A1 WO2007090247 A1 WO 2007090247A1 AU 2007000147 W AU2007000147 W AU 2007000147W WO 2007090247 A1 WO2007090247 A1 WO 2007090247A1
Authority
WO
WIPO (PCT)
Prior art keywords
chamber
nebuliser
liquid
air inlet
nebulisable
Prior art date
Application number
PCT/AU2007/000147
Other languages
French (fr)
Other versions
WO2007090247A8 (en
Inventor
David Bull
Andy Wyatt
Claudia Bonifer
Michael Squires
Original Assignee
Intelligent Medical Technologies Pty Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006900669A external-priority patent/AU2006900669A0/en
Application filed by Intelligent Medical Technologies Pty Limited filed Critical Intelligent Medical Technologies Pty Limited
Publication of WO2007090247A1 publication Critical patent/WO2007090247A1/en
Publication of WO2007090247A8 publication Critical patent/WO2007090247A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222Materials for reducing friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/21General characteristics of the apparatus insensitive to tilting or inclination, e.g. spill-over prevention

Definitions

  • the present invention relates to a nebuliser and will be described hereinafter with reference to this application. However, it will be appreciated that the invention is not limited to this particular field of use.
  • Nebulisers are widely employed in a number of applications, e.g. nebulisation of liquid fuel, moisturisation of air and for sterilisation purposes.
  • One common application is in the medical field.
  • Medical nebulisers provide an aerosol of medication for pulmonary delivery of drugs for the treatment of certain conditions and diseases.
  • Nebulisers have applications for conscious, spontaneously-breathing patients and for controlled, ventilated patients.
  • An important consideration in the design of medical nebulisers is the ability to prevent unwanted loss of nebulisable liquid from the nebulisation chamber.
  • the present invention provides a nebuliser, comprising: a nebulisation chamber having an air inlet, an outlet, a well adapted to contain a nebulisable liquid, an energy source operatively associated with said well for nebulising said nebulisable liquid, and at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber through said air inlet while still permitting sufficient ingress of air into the chamber.
  • the selective flow means is provided on or in the air inlet. In one embodiment the selective flow means is in the form of a plurality of baffles.
  • the baffles are preferably disposed in an overlapping relationship within the air inlet, and may be sufficiently numbered, sized and/or positioned such that air may pass relatively freely into the chamber but egress of nebulisable liquid from the chamber is substantially prevented.
  • the baffles may also be sloped from the air inlet walls toward the nebulisation chamber such that any nebulised liquid impacting thereon is returned to the well for re-nebulisation.
  • the free space between the baffles defines apertures which are sufficiently small such that the surface tension of the nebulisable liquid substantially prevents the egress of nebulisable liquid but sufficiently large to permit the ingress of air into the chamber.
  • the baffles are coated with a surface tension modifier for creating a substantially non-wetting surface thereon.
  • the selective flow means is configured to provide a labyrinthine/circuitous path in the air inlet.
  • the selective flow means are adapted to substantially retain the nebulisable liquid within the nebulisation chamber if the nebuliser is rotated from its generally upright position.
  • the selective flow means may be formed from a readily deformable elastomeric material.
  • selective flow means as used herein is intended to refer to a device/apparatus/formation/barrier which simultaneously allows the flow of air through the inlet passage into the chamber whilst substantially preventing the egress of liquid.
  • the Applicants contemplates a foraminous or multi- perforate plate having apertures of sufficient size, configuration and/or number such that air may pass therethrough and yet nebulisable liquids are substantially retained (within the nebulisation chamber).
  • the selective flow means may be embodied in other forms. It will also be appreciated that the selective flow means should not substantially restrict the passage of air through the chamber. For example, the air inlet should not be restricted to the point whereby the user is forced to draw excessively deep breaths to receive a dose of nebulised liquid, since this may affect the delivered dose.
  • the "air inlet" of the nebulisation chamber comprises the external aperture of the nebuliser and the conduit or tube which depends into the nebulisation chamber.
  • the present Applicants have found that, unlike prior art devices, certain advantages arise in providing a selective flow means between the well and the air inlet of the nebulisation chamber.
  • such an arrangement has drawbacks.
  • the liquid drug contained in the chamber may inconveniently escape from the chamber via the air inlet passage.
  • a direct inlet passage also provides an avenue for contamination of the liquid drug.
  • the Applicants have found that providing a selective flow means between the air inlet and drug well reduces the possibility of liquid drug escaping from the device whilst still enabling a sufficient flow rate of air into and through the chamber to entrain the nebulised liquid.
  • Selective flow means in the form of baffles also assist in extending the life of the device and in its maintenance.
  • the present invention is particularly suitable for the Nebuliser device as described in International PCT Application No. PCT/AU2006/001305, which is incorporated herein by reference.
  • the present invention provides a method of nebulising a nebulisable liquid, comprising the steps of: i. providing a nebulisation chamber having an air inlet, an outlet and a well adapted to contain a nebulisable liquid; ii. providing a nebulisable liquid contained within said well; iii. providing an energy source operatively associated with said well to nebulise said liquid; and iv. nebulising said nebulisable liquid, wherein said nebulisation chamber comprises at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber through said air inlet while still permitting sufficient ingress of air into the chamber.
  • the present invention provides a method of preventing loss of nebulisable liquid via an air inlet of a nebuliser, the nebuliser having a nebulisation chamber, an air inlet and an outlet for the nebulised liquid, the method comprising: providing at least one selective flow means within the nebuliser for
  • the selective flow means is provided within the air inlet.
  • An embodiment of the invention provides the energy source in the form of an ultrasonic transducer which is preferably formed of piezoelectric ceramic material.
  • energy source may also include a curved energy transmission surface which is preferably parabolic.
  • the well may be operatively associated with the energy source by a contact
  • the contact medium having a high energy transmission efficiency.
  • the contact medium is
  • the nebulisable liquid is chosen from the group consisting of: a drug, a solution of a drug and a suspension of a drug.
  • a drug a drug, a solution of a drug and a suspension of a drug.
  • well may contain up to 8 mL of a nebulisable liquid.
  • Figure 1 is a sectional side view of a nebuliser according to the present invention, shown prior to operation and charged with a nebulisable liquid;
  • Figure 2 is a view similar to Figure 1 but showing the nebuliser rotated such that the nebulisable liquid is now undesirably contained in the air inlet passage with the selective flow means substantially preventing the unwanted loss of nebulisable liquid out from the air inlet.
  • the nebuliser 1 includes a nebulisation chamber 2 having a well 3 adapted to contain a nebulisable liquid 4 to be nebulised and an air inlet 5 and an outlet 6.
  • the liquid 4 is a drug solution 7.
  • the well 3 is preferably disposed at the deepest part of the nebulisation chamber 2 and may contain any amount of drug according to the size of the nebuliser 1. However in the preferred embodiment the well contains up to 8 mL of liquid.
  • An energy source in the form of an ultrasonic transducer 8 is operatively associated with the well 3 for nebulising the drug 7.
  • the air inlet 5 includes at least one selective flow means 8 for substantially preventing loss of nebulisable liquid 4 from the chamber 2 while still permitting sufficient ingress of air into the chamber 2.
  • the selective flow means 9 is shown as a plurality of baffles 10 however it will be appreciated by those skilled in the art that other structures may be used for the selective flow means 9.
  • the selective flow means 9 is configured to provide a labyrinthine or circuitous path in the air inlet 5.
  • the baffles 10 are preferably disposed in an overlapping relationship within the air inlet 4 and may be numbered, sized and/or positioned closely together such that air may pass substantially freely into the chamber 2 but egress of nebulisable liquid from the chamber 2 is substantially prevented.
  • the free space between the baffles 10 defines apertures which are sufficiently small such that the surface tension of the nebulisable liquid 4 substantially prevents the egress of nebulisable liquid 4 through the air inlet 5, as best shown in Figure 2. However, the apertures are sufficiently large to permit the ingress of air into the chamber 2.
  • the baffles 10 are preferably sloped from the air inlet 5 walls toward the nebulisation chamber 2 such that any nebulised liquid impacting thereon is returned to the well 3 for re-nebulisation. Further, the baffles 10 may be coated with a surface tension modifier for creating a substantially non- wetting/hydrophobic surface thereon.
  • the selective flow means 9 completely prevents flow of liquid out of the nebuliser 1. Rather, it is intended to restrict the flow of the liquid to such an extent that when the nebuliser 1 is inverted, knocked over or rotated from its generally upright position, the flow of liquid out of the nebuliser 1 is substantially reduced such that the orientation of the nebuliser 1 can be corrected without loss of the entire volume of liquid contained in the nebuliser 1.
  • Another embodiment for example may be a single, or multiple tapered orifices. These orifices may be configured such that they permit ingress of air into the chamber but prevent or at least reduce liquid leaving the chamber.
  • the selective flow means 8 may be formed from a readily deformable elastomeric material.

Abstract

The present invention relates to a nebuliser and method of nebulising a nebulisable liquid. The nebuliser includes a nebulisation chamber having an air inlet, an outlet and a well adapted to contain a nebulisable liquid. An energy source is operatively associated with the well for nebulising the nebulisable liquid, wherein the air inlet comprises at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber while still permitting sufficient ingress of air into the chamber.

Description

"NEBULISER"
FIELD OF THE INVENTION The present invention relates to a nebuliser and will be described hereinafter with reference to this application. However, it will be appreciated that the invention is not limited to this particular field of use.
BACKGROUND OF THE INVENTION
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of the common general knowledge in the field.
Nebulisers are widely employed in a number of applications, e.g. nebulisation of liquid fuel, moisturisation of air and for sterilisation purposes. One common application is in the medical field. Medical nebulisers provide an aerosol of medication for pulmonary delivery of drugs for the treatment of certain conditions and diseases. Nebulisers have applications for conscious, spontaneously-breathing patients and for controlled, ventilated patients. An important consideration in the design of medical nebulisers is the ability to prevent unwanted loss of nebulisable liquid from the nebulisation chamber. Most prior art devices have a direct line of access from the atmospheric air inlet to the nebulisation chamber, and if these devices are inadvertently knocked over then any drug that escapes the chamber is wasted and the user invariably suffers considerable inconvenience by coming into contact with the liquid, and cost since the liquid is typically relatively expensive. Furthermore, this also means that the electronics of the nebuliser may come into contact with liquid, which may irreparably damage the device. See for example, U.S. Patent No.'s 6,357,671; 6,283,118, 3,901,443 and 5,429,302, and International PCT Publication No. WO 94/08727.
It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the abovementioned prior art, or to provide a useful alternative.
DISCLOSURE OF THE INVENTION
In a first aspect the present invention provides a nebuliser, comprising: a nebulisation chamber having an air inlet, an outlet, a well adapted to contain a nebulisable liquid, an energy source operatively associated with said well for nebulising said nebulisable liquid, and at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber through said air inlet while still permitting sufficient ingress of air into the chamber. The selective flow means is provided on or in the air inlet. In one embodiment the selective flow means is in the form of a plurality of baffles. The baffles are preferably disposed in an overlapping relationship within the air inlet, and may be sufficiently numbered, sized and/or positioned such that air may pass relatively freely into the chamber but egress of nebulisable liquid from the chamber is substantially prevented. The baffles may also be sloped from the air inlet walls toward the nebulisation chamber such that any nebulised liquid impacting thereon is returned to the well for re-nebulisation. The free space between the baffles defines apertures which are sufficiently small such that the surface tension of the nebulisable liquid substantially prevents the egress of nebulisable liquid but sufficiently large to permit the ingress of air into the chamber. In related aspects the baffles are coated with a surface tension modifier for creating a substantially non-wetting surface thereon. In related embodiments the selective flow means is configured to provide a labyrinthine/circuitous path in the air inlet. In further embodiments the selective flow means are adapted to substantially retain the nebulisable liquid within the nebulisation chamber if the nebuliser is rotated from its generally upright position. In other embodiments the selective flow means may be formed from a readily deformable elastomeric material. The term "selective flow means" as used herein is intended to refer to a device/apparatus/formation/barrier which simultaneously allows the flow of air through the inlet passage into the chamber whilst substantially preventing the egress of liquid. In other embodiments, for example, the Applicants contemplates a foraminous or multi- perforate plate having apertures of sufficient size, configuration and/or number such that air may pass therethrough and yet nebulisable liquids are substantially retained (within the nebulisation chamber). However, the skilled person will appreciate that the selective flow means may be embodied in other forms. It will also be appreciated that the selective flow means should not substantially restrict the passage of air through the chamber. For example, the air inlet should not be restricted to the point whereby the user is forced to draw excessively deep breaths to receive a dose of nebulised liquid, since this may affect the delivered dose. It will be appreciated that for the purposes herein the "air inlet" of the nebulisation chamber comprises the external aperture of the nebuliser and the conduit or tube which depends into the nebulisation chamber. The present Applicants have found that, unlike prior art devices, certain advantages arise in providing a selective flow means between the well and the air inlet of the nebulisation chamber. In most of the prior art, there is a direct unrestricted passage between the well containing the liquid drug and the air inlet to the chamber. Without wishing to be bound by theory, it is believed that this permits atmospheric air to proceed unhindered into and through the chamber where it entrains the nebulised liquid before being transported to the user via the outlet. However, such an arrangement has drawbacks. For example, if the device is inverted or dropped the liquid drug contained in the chamber may inconveniently escape from the chamber via the air inlet passage. Arguably such a direct inlet passage also provides an avenue for contamination of the liquid drug. The Applicants have found that providing a selective flow means between the air inlet and drug well reduces the possibility of liquid drug escaping from the device whilst still enabling a sufficient flow rate of air into and through the chamber to entrain the nebulised liquid. Selective flow means in the form of baffles also assist in extending the life of the device and in its maintenance. The Applicants contemplate that the present invention is particularly suitable for the Nebuliser device as described in International PCT Application No. PCT/AU2006/001305, which is incorporated herein by reference.
According to a second aspect, the present invention provides a method of nebulising a nebulisable liquid, comprising the steps of: i. providing a nebulisation chamber having an air inlet, an outlet and a well adapted to contain a nebulisable liquid; ii. providing a nebulisable liquid contained within said well; iii. providing an energy source operatively associated with said well to nebulise said liquid; and iv. nebulising said nebulisable liquid, wherein said nebulisation chamber comprises at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber through said air inlet while still permitting sufficient ingress of air into the chamber.
According to a third aspect, the present invention provides a method of preventing loss of nebulisable liquid via an air inlet of a nebuliser, the nebuliser having a nebulisation chamber, an air inlet and an outlet for the nebulised liquid, the method comprising: providing at least one selective flow means within the nebuliser for
substantially preventing egress of nebulisable liquid from the chamber through the air
inlet while still permitting sufficient ingress of air into the chamber. Preferably the selective flow means is provided within the air inlet.
An embodiment of the invention provides the energy source in the form of an ultrasonic transducer which is preferably formed of piezoelectric ceramic material. The
energy source may also include a curved energy transmission surface which is preferably parabolic.
The well may be operatively associated with the energy source by a contact
medium having a high energy transmission efficiency. Preferably the contact medium is
chosen from the group consisting of water, rubbery polymer, gel and oil, or mixtures thereof.
In preferred embodiments the nebulisable liquid is chosen from the group consisting of: a drug, a solution of a drug and a suspension of a drug. Preferably the
well may contain up to 8 mL of a nebulisable liquid.
Unless the context clearly requires otherwise, throughout the description and the
claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the
sense of "including, but not limited to".
Other than in the operating examples, or where otherwise indicated, all numbers
expressing quantities of ingredients or reaction conditions used herein are to be
understood as modified in all instances by the term "about".
BRIEF DESCRIPTION OF THE DRAWINGS
A preferred embodiment of the invention will now be described, by way of
example only, with reference to the accompanying drawings in which: Figure 1 is a sectional side view of a nebuliser according to the present invention, shown prior to operation and charged with a nebulisable liquid; and
Figure 2 is a view similar to Figure 1 but showing the nebuliser rotated such that the nebulisable liquid is now undesirably contained in the air inlet passage with the selective flow means substantially preventing the unwanted loss of nebulisable liquid out from the air inlet.
PREFERRED EMBODIMENT OF THE INVENTION Referring to the drawings, the nebuliser 1 includes a nebulisation chamber 2 having a well 3 adapted to contain a nebulisable liquid 4 to be nebulised and an air inlet 5 and an outlet 6. Preferably, the liquid 4 is a drug solution 7. The well 3 is preferably disposed at the deepest part of the nebulisation chamber 2 and may contain any amount of drug according to the size of the nebuliser 1. However in the preferred embodiment the well contains up to 8 mL of liquid. An energy source in the form of an ultrasonic transducer 8 is operatively associated with the well 3 for nebulising the drug 7.
The air inlet 5 includes at least one selective flow means 8 for substantially preventing loss of nebulisable liquid 4 from the chamber 2 while still permitting sufficient ingress of air into the chamber 2. The selective flow means 9 is shown as a plurality of baffles 10 however it will be appreciated by those skilled in the art that other structures may be used for the selective flow means 9. Preferably the selective flow means 9 is configured to provide a labyrinthine or circuitous path in the air inlet 5.
The baffles 10 are preferably disposed in an overlapping relationship within the air inlet 4 and may be numbered, sized and/or positioned closely together such that air may pass substantially freely into the chamber 2 but egress of nebulisable liquid from the chamber 2 is substantially prevented. The free space between the baffles 10 defines apertures which are sufficiently small such that the surface tension of the nebulisable liquid 4 substantially prevents the egress of nebulisable liquid 4 through the air inlet 5, as best shown in Figure 2. However, the apertures are sufficiently large to permit the ingress of air into the chamber 2. Also, the baffles 10 are preferably sloped from the air inlet 5 walls toward the nebulisation chamber 2 such that any nebulised liquid impacting thereon is returned to the well 3 for re-nebulisation. Further, the baffles 10 may be coated with a surface tension modifier for creating a substantially non- wetting/hydrophobic surface thereon.
It will also understood by persons skilled in the art that it is not essential that the selective flow means 9 completely prevents flow of liquid out of the nebuliser 1. Rather, it is intended to restrict the flow of the liquid to such an extent that when the nebuliser 1 is inverted, knocked over or rotated from its generally upright position, the flow of liquid out of the nebuliser 1 is substantially reduced such that the orientation of the nebuliser 1 can be corrected without loss of the entire volume of liquid contained in the nebuliser 1.
Another embodiment for example may be a single, or multiple tapered orifices. These orifices may be configured such that they permit ingress of air into the chamber but prevent or at least reduce liquid leaving the chamber. The selective flow means 8 may be formed from a readily deformable elastomeric material.
It will be appreciated that the illustrated nebuliser is effective, economical, convenient and simple to use. Although the invention has been described with reference to specific examples, it will be appreciated by those skilled in the art that the invention may be embodied in many other forms.

Claims

CLAIMS:-
1. A nebuliser, comprising: a nebulisation chamber having an air inlet, an outlet, a well adapted to contain a nebulisable liquid, an energy source operatively associated with said well for nebulising said nebulisable liquid, and at least one selective flow means for substantially preventing egress of nebulisable liquid from the chamber through said air inlet while still permitting sufficient ingress of air into the chamber.
2. A nebuliser according to claim 1 wherein said selective flow means is provided on or in said air inlet.
3. A nebuliser according to claim 1 or claim 2 wherein said selective flow means is in the form of one or more foraminous or multi-perforate plates or barriers having apertures of sufficient size, configuration and/or number such that air may pass therethrough and yet said nebulisable liquid is substantially retained.
4. A nebuliser according to claim 1 or claim 2 wherein said selective flow means is in the form of a plurality of baffles.
5. A nebuliser according to claim 4 wherein said baffles are disposed in an overlapping relationship within said air inlet and are sufficiently numbered, sized and/or positioned such that air may pass relatively freely into said chamber but egress of nebulisable liquid from said chamber is substantially prevented.
6. A nebuliser according to any one of claims 1 to 5 wherein said selective flow means is configured to provide a labyrinthine or circuitous path in said air inlet.
7. A nebuliser according to any one of claims 4 to 6 wherein said selective flow means is adapted to substantially retain said nebulisable liquid within said nebulisation chamber if said nebuliser is rotated from its generally upright position.
8. A nebuliser according to any one of claims 4 to 7 wherein said baffles are sloped from said air inlet walls toward said nebulisation chamber such that any nebulised liquid impacting thereon is returned to said well for re- nebulisation.
9. A nebuliser according to any one of claims 4 to 8 wherein the free space between said baffles defines apertures, said apertures begin sufficiently small such that the surface tension of said nebulisable liquid substantially prevents the egress of nebulisable liquid but sufficiently large to permit the ingress of air into said chamber.
10. A nebuliser according to any one of claims 4 to 9 wherein said baffles are coated with a surface tension modifier for creating a substantially non- wetting surface thereon.
11. A nebuliser according to any one of claims 4 to 10 wherein said selective flow means is formed from a readily deformable elastomeric material.
12. A nebuliser according to any one of the preceding claims wherein said energy source is an ultrasonic transducer.
13. A nebuliser according to claim 12 wherein said ultrasonic transducer is formed of piezoelectric ceramic material.
14. A nebuliser according to claim 12 or claim 13 wherein said energy source includes a curved energy transmission surface.
15. A nebuliser according to claim 14 wherein said curved energy transmission surface is parabolic.
16. A nebuliser according to any one of the preceding claims wherein said well is operatively associated with said energy source by a contact medium having a high energy transmission efficiency.
17. A nebuliser according to claim 16 wherein said contact medium is chosen from the group consisting of water, rubbery polymer, gel and oil, or mixtures thereof.
18. A nebuliser according to any one of the preceding claims wherein said nebulisable liquid is chosen from the group consisting of: a drug, a solution of a drug and a suspension of a drug.
19. A nebuliser according to any one of the preceding claims wherein said well contains up to 8 mL of a nebulisable liquid.
20. A method of preventing loss of nebulisable liquid via an air inlet of a nebuliser, said nebuliser having a nebulisation chamber, an air inlet and an outlet for the nebulised liquid, said method comprising: providing at least one selective flow means within said nebuliser for substantially preventing egress of nebulisable liquid from said chamber through said air inlet while still permitting sufficient ingress of air into said chamber.
21. A method according to claim 20 wherein said selective flow means is provided within said air inlet.
22. A method of nebulising a nebulisable liquid, comprising the steps of: i. providing a nebulisation chamber having an air inlet, an outlet and a well adapted to contain a nebulisable liquid; ii. providing a nebulisable liquid contained within said well; iii. providing an energy source operatively associated with said well to
nebulise said liquid; and
iv. nebulising said nebulisable liquid,
wherein said nebulisation chamber comprises at least one selective flow
means for substantially preventing egress of nebulisable liquid from the
chamber through said air inlet while still permitting sufficient ingress of air
into the chamber.
23. A method according to any one of claims 20 to 22 wherein said selective
flow means is in the form of one or more forarninous or multi-perforate
plates or barriers having apertures of sufficient size, configuration and/or
number such that air may pass therethrough and yet said nebulisable liquid is
substantially retained.
24. A method according to any one of claims 20 to 22 wherein said selective flow means is in the form of a plurality of baffles.
25. A method according to claim 24 wherein said baffles are disposed in an
overlapping relationship within said air inlet and are sufficiently numbered, sized and/or positioned such that air may pass relatively freely into said
chamber but egress of nebulisable liquid from said chamber is substantially
prevented.
26. A method according to any one of claims 20 to 25 wherein said selective
flow means is configured to provide a labyrinthine or circuitous path.
27. A method according to any one of claims 20 to 26 wherein said baffles are
adapted to substantially retain said nebulisable liquid within said nebulisation
chamber if said nebuliser is rotated from its generally upright position.
28. A method according to any one of claims 24 to 27 wherein said baffles are sloped from said air inlet walls toward said nebulisation chamber such that any nebulised liquid impacting thereon is returned to said well for re- nebulisation.
29. A method according to any one of claims 24 to 28 wherein the free space between said baffles defines apertures, said apertures begin sufficiently small such that the surface tension of said nebulisable liquid substantially prevents the egress of nebulisable liquid but sufficiently large to permit the ingress of air into said chamber.
30. A method according to any one of claims 24 to 29 wherein said baffles are coated with a surface tension modifier for creating a substantially non- wetting surface thereon.
31. A method according to any one of claims 24 to 30 wherein said baffles are formed from a readily deformable elastomeric material.
PCT/AU2007/000147 2006-02-10 2007-02-12 Nebuliser WO2007090247A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006900669 2006-02-10
AU2006900669A AU2006900669A0 (en) 2006-02-10 Nebuliser VII

Publications (2)

Publication Number Publication Date
WO2007090247A1 true WO2007090247A1 (en) 2007-08-16
WO2007090247A8 WO2007090247A8 (en) 2007-12-13

Family

ID=38344819

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2007/000147 WO2007090247A1 (en) 2006-02-10 2007-02-12 Nebuliser

Country Status (1)

Country Link
WO (1) WO2007090247A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109985297A (en) * 2019-05-17 2019-07-09 深圳市柏明胜医疗器械有限公司 A kind of medicine bottle

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3561444A (en) * 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US4094317A (en) * 1976-06-11 1978-06-13 Wasnich Richard D Nebulization system
US5170782A (en) * 1991-09-12 1992-12-15 Devilbiss Health Care, Inc. Medicament nebulizer with improved aerosol chamber
EP0587380A1 (en) * 1992-09-11 1994-03-16 Medic-Aid Limited Drug delivery arrangement
WO1995015822A1 (en) * 1993-12-09 1995-06-15 The Technology Partnership Plc Liquid spray apparatus and method
AU668343B3 (en) * 1995-10-13 1996-04-26 Peter Moran Inhaler
US20050166918A1 (en) * 2002-05-28 2005-08-04 Andrea Trombi Apparatus for nebulising a liquid, in particular for aerosol therapy
US20050183718A1 (en) * 2004-02-24 2005-08-25 Boehringer Ingelheim International Gmbh Nebulizer

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3561444A (en) * 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US4094317A (en) * 1976-06-11 1978-06-13 Wasnich Richard D Nebulization system
US5170782A (en) * 1991-09-12 1992-12-15 Devilbiss Health Care, Inc. Medicament nebulizer with improved aerosol chamber
EP0587380A1 (en) * 1992-09-11 1994-03-16 Medic-Aid Limited Drug delivery arrangement
WO1995015822A1 (en) * 1993-12-09 1995-06-15 The Technology Partnership Plc Liquid spray apparatus and method
AU668343B3 (en) * 1995-10-13 1996-04-26 Peter Moran Inhaler
US20050166918A1 (en) * 2002-05-28 2005-08-04 Andrea Trombi Apparatus for nebulising a liquid, in particular for aerosol therapy
US20050183718A1 (en) * 2004-02-24 2005-08-25 Boehringer Ingelheim International Gmbh Nebulizer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109985297A (en) * 2019-05-17 2019-07-09 深圳市柏明胜医疗器械有限公司 A kind of medicine bottle

Also Published As

Publication number Publication date
WO2007090247A8 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
US20220088630A1 (en) Aerosol generator
EP2643038B1 (en) Aerosol generator
CN101247898B (en) Ultrasonic aerosol generator
JP5762283B2 (en) Spraying device for ventilator and ventilator having spraying device
EP2361108B1 (en) Aerosol therapy device
US3572660A (en) Device for dispensing inhalable fluids
US7261102B2 (en) Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule
EP3673939A1 (en) Fluid reservoir for an aerosol generator and aerosol generator comprising the fluid reservoir
CA2883583C (en) Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element
WO2016102308A1 (en) Aerosol delivery device and operating method for the aerosol delivery device
US20100288271A1 (en) System for Artificial Respiration of Persons
CN108686287A (en) Fluid delivery system, its operating method and the oscilator system used in it
WO2007090247A1 (en) Nebuliser
US5612226A (en) Gas/liquid contact apparatus
EP3666315A1 (en) Aerosol delivery device and method of operating the aerosol delivery device
TWI720025B (en) Sterile liquid dispenser
JPH05137788A (en) Ultrasonic nebulier
JPH1133118A (en) Method for disposing of gas discharged from respirator and sterilizer for the discharged gas
AU2002327586A1 (en) Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07701478

Country of ref document: EP

Kind code of ref document: A1